-
1
-
-
84861581164
-
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
-
Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
-
(2012)
Nat. Genet.
, vol.44
, pp. 685-689
-
-
Barbieri, C.E.1
-
2
-
-
84930225081
-
Integrative clinical genomics of advanced prostate cancer.
-
Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215-1228 (2015).
-
(2015)
Cell
, vol.161
, pp. 1215-1228
-
-
Robinson, D.1
-
3
-
-
84930195799
-
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
-
Cooper, C. S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367-372 (2015).
-
(2015)
Nat. Genet.
, vol.47
, pp. 367-372
-
-
Cooper, C.S.1
-
4
-
-
84933277410
-
Spatial genomic heterogeneity within localized, multifocal prostate cancer
-
Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736-745 (2015).
-
(2015)
Nat. Genet.
, vol.47
, pp. 736-745
-
-
Boutros, P.C.1
-
5
-
-
0033551374
-
MYC oncogenes and human neoplastic disease.
-
Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016 (1999).
-
(1999)
Oncogene
, vol.18
, pp. 3004-3016
-
-
Nesbit, C.E.1
Tersak, J.M.2
Prochownik, E.V.3
-
6
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
Beltran, H. et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 1, 487-495, (2011).
-
(2011)
Cancer Discov.
, vol.1
, pp. 487-495
-
-
Beltran, H.1
-
7
-
-
67349257845
-
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
-
Liu, W. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 15, 559-565 (2009).
-
(2009)
Nat. Med.
, vol.15
, pp. 559-565
-
-
Liu, W.1
-
8
-
-
84872732113
-
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
-
Aryee, M. J. et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci. Transl. Med. 5, 169ra110 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 169ra110
-
-
Aryee, M.J.1
-
9
-
-
84928405167
-
The evolutionary history of lethal metastatic prostate cancer
-
Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353-357 (2015).
-
(2015)
Nature
, vol.520
, pp. 353-357
-
-
Gundem, G.1
-
10
-
-
84887429673
-
Tracking the clonal origin of lethal prostate cancer
-
Haffner, M. C. et al. Tracking the clonal origin of lethal prostate cancer. J. Clin. Invest. 123, 4918-4922 (2013).
-
(2013)
J. Clin. Invest
, vol.123
, pp. 4918-4922
-
-
Haffner, M.C.1
|